SCHEMBL365218

SCHEMBL365218

CC([O])c1cccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1975275 0.82
SCHEMBL7981769 0.82
SCHEMBL29507088 0.82
SCHEMBL30391667 0.81
SCHEMBL10446411 0.81 CFTR (0.58)
SCHEMBL10236 0.81
SCHEMBL2493545 0.81 CFTR (0.58)
Hydrochloric Acid SCHEMBL20378295 0.80 CFTR (0.52)
Bromide SCHEMBL16227605 0.80 CFTR (0.52)
Hydrochloric Acid SCHEMBL27777635 0.80 CFTR (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5219863-A Treating hypertension and congestive heat failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-06-15 US claimed
US-5198439-A Hypotensive agents, congestive heart failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-03-30 US claimed
US-5198434-A ANGIOTENSIN II ANTAGONIZING FUSED PYRIDINYLOXY CONTAINING DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-03-30 US claimed
EP-0499414-A2 Pyridine derivatives as angiotensin II antagonists, processes for their preparation and pharmaceutical compositions containing them ZENECA LIMITED (GB) 1992-08-19 EP claimed
EP-0499415-A1 Pyridine and quinoline derivatives, processes for their manufacture and their use as angiotensin II antagonists ZENECA LIMITED (GB) 1992-08-19 EP claimed
EP-0487252-A1 Quinoline and 1,5-Naphthyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them ZENECA LIMITED (GB) 1992-05-27 EP claimed
EP-0453210-A2 Pyridine derivatives ZENECA LIMITED (GB) 1991-10-23 EP claimed
US-9096531-B2 Fused imidazole derivative TOA EIYO LTD. (JP) 2015-08-04 US disclosed
EP-2578573-A1 FUSED IMIDAZOLE DERIVATIVE TOA Eiyo Ltd. (JP) 2013-04-10 EP disclosed
US-20130065896-A1 FUSED IMIDAZOLE DERIVATIVE TOA EIYO LTD. (JP) 2013-03-14 US disclosed
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed
US-7223755-B2 Hydroxymorpholinone derivative and medicinal use thereof SENJU PHARMACEUTICAL CO., LTD. (JP) 2007-05-29 US disclosed
US-20050176704-A1 Hydroxymorpholinone derivative and medicinal use thereof SENJU PHARMACEUTICAL CO., LTD. (JP) 2005-08-11 US disclosed
EP-0499414-A2 Pyridine derivatives as angiotensin II antagonists, processes for their preparation and pharmaceutical compositions containing them ZENECA LIMITED (GB) 1992-08-19 EP disclosed
US-5130318-A Hypotensive agents and for treatment of congestive heart failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-07-14 US disclosed
EP-0487252-A1 Quinoline and 1,5-Naphthyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them ZENECA LIMITED (GB) 1992-05-27 EP disclosed
EP-0453210-A2 Pyridine derivatives ZENECA LIMITED (GB) 1991-10-23 EP disclosed
US-5049665-A Cephalosporin derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-09-17 US disclosed
US-4918070-A Antibiotics BANYU PHARMACEUTICAL CO., LTD. (JP) 1990-04-17 US disclosed
EP-0280240-A2 Cephalosporin derivatives, process for their preparation and antibacterial agents Banyu Pharmaceutical Co., Ltd. (JP) 1988-08-31 EP disclosed